$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
厄布利塞治疗淋巴瘤有副作用吗
2025-10-19 11:44:20
Check Details
厄布利塞治疗淋巴瘤效果怎么样
2025-10-19 11:44:20
Check Details
注射苯达莫司汀为什么要多喝水?
2025-10-19 11:44:20
Check Details
普乐沙福副作用的缓解方法?
2025-10-19 11:44:20
Check Details
他泽司他副作用处理方法?
2025-10-19 11:44:20
Check Details
厄布利塞治疗淋巴细胞肿瘤的效果以及常见不良反应?
2025-10-19 11:44:20
Check Details
洛莫司汀有哪些注意事项?
2025-10-19 11:44:20
Check Details
塞利尼索临床治疗效果?
2025-10-19 11:44:20
Check Details
度维利塞的不良反应管理?
2025-10-19 11:44:20
Check Details
度维利塞治疗T细胞淋巴瘤效果?
2025-10-19 11:44:20
Check Details
伏立诺他导致血小板减少、贫血的处理方法?
2025-10-19 11:44:20
Check Details
洛莫司汀和福莫司汀的区别?
2025-10-19 11:44:20
Check Details
1
2
...
7352
7353
7354
7355
7356
7357
7358
...
10232
10233
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Ceritinib for ALK-Positive NSCLC: Indication, Dosing, and Safety Management
2
Acalabrutinib in CLL/SLL Survival Expectation: ELEVATE-TN and ASCEND Long-Term PFS, OS
3
Bosutinib for CML: Time to Response, BCR-ABL Monitoring, and Molecular Remission
4
Bedaquiline for Drug-Resistant TB: 24-Week Regimen, Combination Duration, and When to Stop or Extend
5
Acalabrutinib Dosing and Combination Regimens: CLL/SLL, MCL, Safety Adjustments
6
Enzalutamide for Prostate Cancer: Managing Fatigue, Dizziness, Hypertension, and Serious Neurocardiovascular Risks
7
Bosutinib for Ph+ CML: Indications, Dosing Adjustments, and Hepatic/Renal Safety
8
Tamoxifen Long-Term Safety: Vigilance for Thrombosis and Endometrial Risks
9
Acoramidis for ATTR-CM: Disease Progression Is Not Equivalent to Drug Resistance
10
Lorlatinib Contraindications and Safety Warnings: Six Key Risks to Monitor
11
AZA+VEN+IVO Triplet Therapy for Newly Diagnosed IDH1 AML: High Response Rates and Durable Efficacy
12
Dacomitinib for EGFR-Mutant NSCLC: Dosing, Switching, and Safety Profile